Ilenia Calcaterra: Patient-Level Real-World Outcomes of Emicizumab in Acquired Hemophilia A
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared Emmanuel J Favaloro‘s post on LinkedIn, adding:
”Pleased to see our recent work on Emicizumab in Acquired Hemophilia A published in Seminars in Thrombosis and Hemostasis and shared by the Editor-in-Chief, Prof. Emmanuel J. Favaloro.
In this study we report real-world clinical experience and patient-level outcomes on the use of Emicizumab in a rare and complex bleeding disorder.
Our findings highlight its potential role in improving bleeding control and reducing hospitalization in selected patients with Acquired Hemophilia A.
Rare diseases require rigorous research, careful clinical judgment, and strong collaboration across centers.
Grateful to all colleagues who contributed to this work.”
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared on LinkedIn about a recent article by Ilenia Calcaterra et al, published in Seminars in Thrombosis and Hemostasis:
”Emicizumab in Acquired Hemophilia A.
Recently released online in Seminars in Thrombosis and Hemostasis.
Enjoy!”
Title: Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis
Authors: Ilenia Calcaterra, Carmine De Luca, Guido D’Errico, Ciro Miele, Chiara Caputo, Raffaele Russo, Paolo Conca, Ernesto Cimino, Anna Guida, Antonella Tufano, Matteo Di Minno
Read the Full Article on Seminars in Thrombosis and Hemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 14:06Hossam El Benawi: Intensive Blood Pressure Reduction May Worsen Outcomes After Thrombectomy
-
Apr 15, 2026, 13:51Matías J Alet: Hospital Carlos Saporiti on the Path to Essential Stroke Center Recognition
-
Apr 15, 2026, 13:39Congratulations to Sandy Middleton for Taking the 2026 HESTA Australian Nursing and Midwifery Awards – Stroke Foundation
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC